Latest Insider Transactions at Bionik Laboratories Corp. (BNKL)
This section provides a real-time view of insider transactions for Bionik Laboratories Corp. (BNKL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bionik Laboratories Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bionik Laboratories Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Andre Jacques Auberton Herve Director |
BUY
Conversion of derivative security
|
Indirect |
186,111
+14.37%
|
$0
$0.6 P/Share
|
|
Jun 13
2023
|
Remi Gaston Dreyfus Director |
BUY
Conversion of derivative security
|
Indirect |
3,102,878
+38.69%
|
$0
$0.6 P/Share
|
|
Jun 09
2023
|
Andre Jacques Auberton Herve Director |
BUY
Open market or private purchase
|
Indirect |
650,000
+41.32%
|
$0
$0.6 P/Share
|
|
Jun 09
2023
|
Remi Gaston Dreyfus Director |
BUY
Open market or private purchase
|
Indirect |
180,555
+9.05%
|
$0
$0.6 P/Share
|
|
Jun 09
2023
|
Charles Matine Director |
BUY
Open market or private purchase
|
Direct |
180,555
+46.59%
|
$0
$0.6 P/Share
|
|
Mar 31
2022
|
Remi Gaston Dreyfus Director |
BUY
Conversion of derivative security
|
Indirect |
77,887
+4.6%
|
$700,983
$9.5 P/Share
|
|
Jul 15
2021
|
Andre Jacques Auberton Herve Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
59,378
+9.19%
|
$178,134
$3.38 P/Share
|
|
Jul 15
2021
|
Remi Gaston Dreyfus Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
120,759
+3.54%
|
-
|
|
Mar 29
2021
|
Remi Gaston Dreyfus Director |
BUY
Grant, award, or other acquisition
|
Indirect |
61,256
+3.98%
|
-
|
|
Mar 29
2021
|
Peter Gerald Malone Director |
BUY
Open market or private purchase
|
Direct |
26,430
+50.0%
|
-
|
|
Mar 29
2021
|
Charles Matine Director |
BUY
Open market or private purchase
|
Direct |
26,430
+50.0%
|
-
|
|
Mar 29
2021
|
Audrey Thevenon Director |
BUY
Open market or private purchase
|
Direct |
26,430
+50.0%
|
-
|
|
Mar 29
2021
|
Joseph R Martin Director |
BUY
Open market or private purchase
|
Direct |
26,430
+50.0%
|
-
|
|
Mar 26
2021
|
Remi Gaston Dreyfus Director |
BUY
Open market or private purchase
|
Indirect |
135,560
+8.72%
|
-
|
|
Mar 26
2021
|
Andre Jacques Auberton Herve Director |
BUY
Open market or private purchase
|
Direct |
95,149
+50.0%
|
-
|